The major risk alleles that influence the development of age-related macular degeneration do not predict response to therapy for the condition, a substudy of the CATT trial indicates.
Author: The Medical News
Sucampo’s RESCULA 0.15% now available by prescription across the U.S.
Sucampo Pharmaceuticals, Inc. today announced that RESCULA (unoprostone isopropyl ophthalmic solution) 0.15% is now available by prescription across the United States. The U.S. Food and Drug Administration (FDA) approved a sNDA for RESCULA for the lowe…
MSU to launch levetiracetam clinical trial for treatment of African children with epilepsy
Determined to bring relief to seizure victims, a Michigan State University research team this month begins a groundbreaking clinical drug trial that could help prevent a quarter-million African children from developing epilepsy each year.
Pediatric blindness etiology varies around the globe
The causes and prevalence of blindness in children vary markedly by geography, presumably as a proxy for socioeconomic factors influencing prevention and treatment schemes, conclude the authors of a literature review.
Dompé initiates enrollment in rhNGF phase I/II REPARO study for neurotrophic keratitis
The first patient has been enrolled in the phase I/II REPARO study, the first international clinical trial evaluating the ophthalmological use of a topical solution of recombinant human Nerve Growth Factor (rhNGF) for the treatment of moderate to sever…
Castle Biosciences launches MyUvealMelanoma website
Castle Biosciences Inc., a leading developer of prognostic tests for rare cancers, announced today the launch of MyUvealMelanoma.com, a website created to educate newly diagnosed patients, their families and healthcare providers about the most common f…
Amblyopia screening guidelines updated
The American Association for Pediatric Ophthalmology and Strabismus, the professional body for pediatric eye care, has issued revised guidelines for preschool vision screening based on new evidence.
CATT study clarifies value of genetic testing for age-related macular degeneration
New findings from a landmark clinical trial show that although certain gene variants may predict whether a person is likely to develop age-related macular degeneration (AMD), a potentially blinding eye disease that afflicts more than nine million Ameri…
Researchers describe novel antiviral property of cholesterol-25-hydroxylase
A team of UCLA-led researchers has identified a protein with broad virus-fighting properties that potentially could be used as a weapon against deadly human pathogenic viruses such as HIV, Ebola, Rift Valley Fever, Nipah and others designated “priority…
Sucampo, R-Tech Ueno and Takeda file patent infringement lawsuit against Anchen for AMITIZA
Sucampo Pharmaceuticals, Inc. announced that it, together with R-Tech Ueno, Ltd., Sucampo AG, and Takeda Pharmaceutical Company Limited and certain affiliates of Takeda, has filed a patent infringement lawsuit against Anchen Pharmaceuticals, Inc., whic…
Enzyme therapy slows progression of Batten disease in dogs
Batten disease is a rare, fatal genetic disorder that affects children. Currently, no effective treatment exists for the disease, which ultimately kills all who are affected. Dachshunds also suffer from Batten disease, and now researchers from the Univ…
Taro, Sun Pharma mutually agree to terminate merger agreement
Taro Pharmaceutical Industries Ltd. and Sun Pharmaceutical Industries Ltd. announced today that they have mutually agreed to terminate their merger agreement, announced in August 2012, pursuant to which all shareholders of Taro would have received a ca…
Northwestern Medicine to open new Outpatient Center in Glenview, Illinois
Northwestern Medicine today announced that on March 1 it will open a new Outpatient Center at 2701 Patriot Boulevard in Glenview, Illinois. At this new center, 20-30 physicians will offer patients a wide range of primary care and specialty clinical ser…
Social networking sites could effectively prevent HIV infection among at-risk groups
Facebook and other social networking technologies could serve as effective tools for preventing HIV infection among at-risk groups, new UCLA research suggests.
Selective laser trabeculoplasty promising for glaucoma
Selective laser trabeculoplasty leads to significant reductions in intraocular pressure in people with primary open-angle glaucoma, a study has found.
Viral conjunctivitis: potential new treatment
Viral conjunctivitis is a highly contagious infection, often causing major ophthalmic epidemics. There is no approved acute treatment currently approved by the FDA for viral conjunctivitis. A safe broad-spectrum antiviral agent is needed to treat this …
AAPOS committee revises guidelines for automated preschool vision screening
The Vision Screening Committee of the American Association for Pediatric Ophthalmology and Strabismus, the professional organization for pediatric eye care, has revised its guidelines for automated preschool vision screening based on new evidence. The …
Cause of esodeviation differs in children, adults
Children who present with acute-onset esodeviation should be investigated for underlying central nervous system disorders, study findings indicate.
Central field loss creates driving hazard
People with central field loss experience a range of difficulties when driving that could pose a danger to themselves and pedestrians, researchers believe.
Reprogramming eye cells that enable night vision may one day treat retinitis pigmentosa
Doctors may one day treat some forms of blindness by altering the genetic program of the light-sensing cells of the eye, according to scientists at Washington University School of Medicine in St. Louis.